BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Clinical Outcome
4 results:

  • 1. Tumor Budding and PDC Grade Are Stage Independent Predictors of clinical outcome in Mismatch Repair Deficient colorectal cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pooled Analysis of clinical outcome of Patients with Chemorefractory Metastatic colorectal cancer Treated within Phase I/II clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.
    Sartore-Bianchi A; Amatu A; Bonazzina E; Stabile S; Giannetta L; Cerea G; Schiavetto I; Bencardino K; Funaioli C; Ricotta R; Cipani T; Schirru M; Gambi V; Palmeri L; Carlo-Stella G; Rusconi F; Di Bella S; Burrafato G; Cassingena A; Valtorta E; Lauricella C; Pazzi F; Gambaro A; Ghezzi S; Marrapese G; Tarenzi E; Veronese S; Truini M; Vanzulli A; Siena S
    Target Oncol; 2017 Aug; 12(4):525-533. PubMed ID: 28669023
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results.
    Gryc T; Ott O; Putz F; Knippen S; Raptis D; Fietkau R; Strnad V
    Brachytherapy; 2016; 15(6):865-872. PubMed ID: 27720203
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases.
    Antoniou A; Lovegrove RE; Tilney HS; Heriot AG; John TG; Rees M; Tekkis PP; Welsh FK
    Surgery; 2007 Jan; 141(1):9-18. PubMed ID: 17188163
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.